Fri, Sep 19, 2014, 8:38 PM EDT - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Qiagen NV Message Board

accurateinformation 14 posts  |  Last Activity: Sep 8, 2014 1:50 PM Member since: Oct 16, 2001
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    unidentified respiratory virus....

    by syslak Sep 8, 2014 10:12 AM
    accurateinformation accurateinformation Sep 8, 2014 1:50 PM Flag

    That virus is enterovirus 68 and the GNMK test does not detect it or even cross-react with it according to their 510(k) documents on the FDA website.

    So, it doesn't affect GNMK business at all.

  • Reply to

    Man, sorry for you guys that got hosed

    by smithts777 Sep 6, 2014 2:51 PM
    accurateinformation accurateinformation Sep 7, 2014 1:05 PM Flag

    So, in addition to being psychotic you are also paranoid too?

    Nobody has "hacked" your computer. Multiple times you have claimed that it is you yourself that is deleting your posts, or have you "forgotten" those postings?

    The fact is that it is Yahoo deleting your posts. After all, harassment, use of derogatory language, and spamming are all Terms of Service violations...and something you do with almost every one of your posts.

  • accurateinformation accurateinformation Aug 21, 2014 1:23 PM Flag

    Looks like your harassment of them backfired since they appointed a new board member yesterday that also serves in the capacity of chief investment officer at Lurie Holdings, Inc.

    How long have you had these mental problems?

  • accurateinformation accurateinformation Aug 7, 2014 9:33 AM Flag

    Looks like bd is correct. NPSH is not an ebola play.

    "U.S. health regulators on Wednesday authorized the use of an Ebola diagnostic test developed by the Pentagon to help contain the world's worst outbreak of the deadly virus.

    The move was one of a number of steps taken by the U.S. government this week to address the highly contagious disease that has killed more than 930 people in Africa and sickened hundreds more, including two Americans being treated in Atlanta.

    The diagnostic test was authorized for use abroad on military personnel, aid workers and emergency responders in laboratories designated by the Department of Defense to respond to the Ebola outbreak, the U.S. Food and Drug Administration said.

    The test, called DoD EZ1 Real-time RT-PCR Assay, is designed for use on individuals who have symptoms of Ebola infection, who are at risk for exposure or who may have been exposed. It can take as long as 21 days for symptoms to appear after infections."

  • accurateinformation by accurateinformation Aug 1, 2014 10:03 PM Flag

    ...with the PR announcing that a Roche shill is now on board with ENZ after having lost all respect anyone had for him due to his Roche shilling.

  • Reply to

    accurate information

    by blondiegoodgirl Jun 7, 2014 5:28 PM
    accurateinformation accurateinformation Jun 7, 2014 7:44 PM Flag

    Unlike you, I have mocked nobody and only sated factual information.

    Sentiment: Strong Sell

  • Reply to

    new patent

    by ohnorash Jun 6, 2014 1:44 PM
    accurateinformation accurateinformation Jun 6, 2014 9:20 PM Flag

    Based on the action on today's pps, it appears the street was as unimpressed as I was about the patent

    Sentiment: Strong Sell

  • Reply to

    new patent

    by ohnorash Jun 6, 2014 1:44 PM
    accurateinformation accurateinformation Jun 6, 2014 2:41 PM Flag

    So far none of their gene therapy vectors, including this newest one, have resulted in a singe product that has met the rigor required for FDA approval.

    Sentiment: Strong Sell

  • Reply to

    lift off in 5, 4, 3, ...

    by ohnorash Jun 4, 2014 11:35 AM
    accurateinformation accurateinformation Jun 5, 2014 9:10 AM Flag

    You tell me. I don't drink alcohol.

  • Reply to

    lift off in 5, 4, 3, ...

    by ohnorash Jun 4, 2014 11:35 AM
    accurateinformation accurateinformation Jun 4, 2014 3:51 PM Flag


    What a doofus

  • Reply to

    Patent trols

    by accurateinformation May 19, 2014 4:36 PM
    accurateinformation accurateinformation May 19, 2014 4:36 PM Flag

    Patent trolls, not trols.....

  • accurateinformation by accurateinformation May 19, 2014 4:36 PM Flag

    In case you’re not an intellectual property practitioner, there exists a mythical creature known as a patent troll who resides in the underbelly of the world of legality. Patent trolls are evil beings whose sole purpose in life is to extort money from their victims for no legitimate purpose. These patent holders don’t use their patents to make anything themselves; instead, they assert patent infringement claims against entities that are productive, and often walk away with wads of cash in hand. They frustrate big and small companies alike, and their nefarious deeds can lead to hundreds of thousands of dollars in legal fees over the course of a patent’s lifetime.

    Typically those in charge at companies facing a patent shakedown are quick to pass the claims off to their legal teams, but sometimes, enough is enough. Sometimes, a “less than cordial” response is required when one is faced with a patent troll’s irritating threats. Sometimes patent trolls need to be trolled.

  • Reply to

    Analyst call

    by stkwhizguru333 May 7, 2014 10:29 AM
    accurateinformation accurateinformation May 7, 2014 11:32 AM Flag

    The big names are worried about the money they put into this POS. That is the only reason they were on the call.

    Sentiment: Strong Sell

  • accurateinformation by accurateinformation Apr 7, 2014 10:48 AM Flag

    Roche Acquires POC MDx Firm Iquum
    April 07, 2014

    By a GenomeWeb staff reporter

    NEW YORK (GenomeWeb News) — Roche said today that it has acquired Iquum, a privately held company developing point-of-care molecular diagnostics.

    Under the terms of the agreement, Roche will pay IQuum shareholders $275 million upfront and up to $175 million in contingent product-related milestones. Once the transaction is complete, pending customary closing conditions, Marlborough, Mass.-based IQuum will be integrated into Roche Molecular Diagnostics.

    The acquisition provides Roche with access to Iquum's Liat (laboratory-in-a-tube) System, a point-of-care molecular testing system, as well as the Liat Influenza A/B assay, a rapid, near-patient test to detect and differentiate influenza A and B. Both the system and the assay have been CE marked and received 510(k) clearance from the US Food and Drug Administration.

    "With IQuum, we further strengthen our molecular diagnostics offerings with cutting-edge technology and products that serve the point-of-care segment," Roland Diggelmann, COO of Roche Diagnostics, said in a statement. "We welcome IQuum's employees, who will continue to focus on the development and manufacturing of the Liat Analyzer and assays."

    Last year, Iquum was named as one of three firms (along with BioFire Diagnostics, now part of BioMérieux; and Focus Diagnostics, a Quest Diagnostics subsidiary) to share more than $23 million from the US Department of Defense to develop a platform and assays to detect biological warfare agents.

23.64-0.20(-0.84%)Sep 19 3:59 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.